Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioCancell submits IND application to the FDA for BC-819 in bladder cancer

Dec. 19, 2007

EMEA issues positive opinion recommending conditional approval of GSK's Tyverb

Dec. 18, 2007

Chugai's Xeloda obtains Japanese approval for new indication in colon cancer

Dec. 18, 2007

ImClone initiates phase II clinical trial of IMC-1121B for metastatic malignant melanoma

Dec. 18, 2007

New therapeutics for cancer covered in recent patent literature

Dec. 18, 2007

Phase II data on VNP-40101M in elderly AML patients reported

Dec. 18, 2007

Signs of activity seen with CPX-351 in leukemia, myelodysplastic syndrome

Dec. 18, 2007

Japan's NHI drug reimbursement price list includes Chugai's Tarceva

Dec. 17, 2007

Chroma announces results from phase I study of cancer therapy CHR-2797

Dec. 17, 2007

Mitsubishi Tanabe Pharma reports positive preclinical data on novel tyrosine kinase inhibitor AV-412

Dec. 17, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...